GEROTHERAPEUTIX Trademark

Trademark Overview


On Thursday, February 27, 2025, a trademark application was filed for GEROTHERAPEUTIX with the United States Patent and Trademark Office. The USPTO has given the GEROTHERAPEUTIX trademark a serial number of 99059580. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 25, 2025. This trademark is owned by SENOTHERAPEUTIX, Inc.. The GEROTHERAPEUTIX trademark is filed in the Pharmaceutical Products, Personal and Legal & Social Services categories with the following description:

Anti-aging therapy;Anti-aging services;Anti-aging research;Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders;Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders;Development of pharmaceutical preparations and medicines;Research and development of pharmaceuticals for the treatment of age-related diseases and cancer;Testing, inspection, research, or development of pharmaceutical preparations for age therapy and gene therapy;Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics;Peptides for use in age-related diseases and cancer;Peptides for use in skin conditions;Anti-aging peptides;Peptides for use in prevention of radiation damage;Peptides for use in treatment of radiation damage;Peptides for use in prevention of radiation related diseases;Peptides for use in treatment of ...

Medical advisory services;Medical advisory services, namely, anti-aging services;Medical advisory services, namely, prevention and treatment of age-related disorders;Medical testing services;Medical testing services, namely, anti-aging services;Medical testing services, namely, prevention and treatment of age-related disorders;Medical services in the field of anti-aging;Medical services in the field of senescent cells;Medical services in the field of age-related disorders;Biopsy services;Biopsy services related to biologic age;Biopsy services related to biological age scoring;Biopsy services related to determining a number or percentage of senescent cells;Laboratory services;Laboratory services related to biologic age;Laboratory services related to biological age scoring;Laboratory services related to determining a number or percentage of senescent cells;Non-invasive testing;Non-invasive testing related to biologic age;Non-invasive testing related to biological age scoring;Non-invasive...
gerotherapeutix

General Information


Serial Number99059580
Word MarkGEROTHERAPEUTIX
Filing DateThursday, February 27, 2025
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the word GEROTHERAPEUTIX in stylized black font where the X is formed by a partial lemniscate in blue.
Goods and ServicesAnti-aging therapy;Anti-aging services;Anti-aging research;Pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders;Gene therapy-based pharmaceutical products for the prevention and treatment of cancer and other age-related skin disorders;Development of pharmaceutical preparations and medicines;Research and development of pharmaceuticals for the treatment of age-related diseases and cancer;Testing, inspection, research, or development of pharmaceutical preparations for age therapy and gene therapy;Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics;Peptides for use in age-related diseases and cancer;Peptides for use in skin conditions;Anti-aging peptides;Peptides for use in prevention of radiation damage;Peptides for use in treatment of radiation damage;Peptides for use in prevention of radiation related diseases;Peptides for use in treatment of radiation related diseases;Peptides for use in treatment of obesity;Peptides for use in weight loss regimens, Peptides for use in treatment of obesity in combination with other drugs;Gene therapy research;Gene therapy research related to anti-aging;Gene therapy research related to cancer;Gene therapy related to prevention and treatment of radiation damage and radiation related diseases;Gene therapy related to treatment of obesity;Gene therapy related to weight loss regimens;Gene therapy related to treatment of obesity in combination with other drugs;Biologic age scoring;Statistical scoring to determine a biologic age score of a patient;Medical services;Medical services, namely, anti-aging services;Medical services, namely, prevention and treatment of age-related disorders;Medical research services;Medical research services, namely, anti-aging services;Medical research services, namely, prevention and treatment of age-related disorders
Goods and ServicesMedical advisory services;Medical advisory services, namely, anti-aging services;Medical advisory services, namely, prevention and treatment of age-related disorders;Medical testing services;Medical testing services, namely, anti-aging services;Medical testing services, namely, prevention and treatment of age-related disorders;Medical services in the field of anti-aging;Medical services in the field of senescent cells;Medical services in the field of age-related disorders;Biopsy services;Biopsy services related to biologic age;Biopsy services related to biological age scoring;Biopsy services related to determining a number or percentage of senescent cells;Laboratory services;Laboratory services related to biologic age;Laboratory services related to biological age scoring;Laboratory services related to determining a number or percentage of senescent cells;Non-invasive testing;Non-invasive testing related to biologic age;Non-invasive testing related to biological age scoring;Non-invasive testing related to determining a number or percentage of senescent cells;Prevention of radiation damage;Treatment of radiation damage;Prevention of radiation related diseases;Treatment of radiation related diseases;Treatment of obesity;Weight loss regimens;Treatment of obesity in combination with other drugs;Anti-aging cream;Anti-aging serum;Cosmetic anti-aging products;Cosmetic preparations;Cosmetic research;Cosmetic creams for skin care;Cosmetic preparations for skin care;Peptides for use in cosmetics;Anti-aging peptides for use in cosmetics;Development of cosmetic preparations;Research and development of cosmetic preparations;Consulting services in the fields of anti-aging and cosmetics;Biologic age scoring for use in cosmetics;Statistical scoring to determine a biologic age score of an individual

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 27, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 27, 2025
Primary Code045
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSENOTHERAPEUTIX, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSurfside, FL 33154

Trademark Events


Event DateEvent Description
Thursday, February 27, 2025NEW APPLICATION ENTERED
Thursday, February 27, 2025APPLICATION FILING RECEIPT MAILED
Tuesday, September 9, 2025NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, September 10, 2025ASSIGNED TO EXAMINER
Thursday, September 25, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 25, 2025NON-FINAL ACTION WRITTEN
Thursday, September 25, 2025NON-FINAL ACTION E-MAILED
Tuesday, September 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED